Greenhalf, William
University of Liverpool · University College London
15 papers on CoChatORCID 0000-0002-1865-3195
Most cited papers
- Verified
Therapeutic developments in pancreatic cancer: current and future perspectives
Neoptolemos, J. P., Kleeff, J., Michl, P., Costello, E., Greenhalf, W., & Palmer, D. H. (2018) · Nature Reviews Gastroenterology & Hepatology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 1,170
- Verified
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., Duyvesteyn, H. M. E., Ginn, H. M., Mentzer, A. J., Tuekprakhon, A., et al. (2022) · Cell
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 930
- Verified
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 482
- Verified
PALB2 mutations in European familial pancreatic cancer families
Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics
Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancer
Cited by 278
- Verified
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira, E., Rawlik, K., Bretherick, A. D., Qi, T., Wu, Y., Nassiri, I., McConkey, G. A., Zechner, M., Klaric, L., Griffiths, F., et al. (2023) · Nature
Genetic Associations and EpidemiologyCOVID-19 Clinical Research Studies
Cited by 225
- Verified
Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma
Radon, T. P., Massat, N. J., Jones, R., Alrawashdeh, W., Dumartin, L., Ennis, D., Duffy, S. W., Kocher, H. M., Pereira, S. P., Guarner (posthumous), L., et al. (2015) · Clinical Cancer Research
Pancreatic and Hepatic Oncology ResearchAdvanced Proteomics Techniques and Applications
Cited by 203
- Verified
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
Rachakonda, P. S., Bauer, A. S., Xie, H., Campa, D., Rizzato, C., Canzian, F., Beghelli, S., Greenhalf, W., Costello, E., Schanne, M., et al. (2013) · PLoS ONE
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 93
- Verified
Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus
Jenkinson, C., Elliott, V. L., Evans, A., Oldfield, L., Jenkins, R. E., O'Brien, D. P., Apostolidou, S., Gentry-Maharaj, A., Fourkala, E.-O., Jacobs, I. J., et al. (2016) · Clinical Cancer Research
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 87
- Verified
International registries of families at high risk of pancreatic cancer
Greenhalf, W., Malats, N., Nilsson, M., Bartsch, D., & Neoptolemos, J. (2008) · Pancreatology
Bee Products Chemical AnalysisPancreatic and Hepatic Oncology Research
Cited by 85
- Verified
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
Tonack, S., Jenkinson, C., Cox, T., Elliott, V, Jenkins, R. E., Kitteringham, N. R., Greenhalf, W., Shaw, V, Michalski, C. W., Friess, H., et al. (2013) · British Journal of Cancer
Pancreatic and Hepatic Oncology ResearchAdvanced Proteomics Techniques and Applications
Cited by 70
- Verified
Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer
Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R. E., Kitteringham, N., Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2009) · Journal of Proteome Research
Pancreatic and Hepatic Oncology ResearchAdvanced Proteomics Techniques and Applications
Cited by 44
- Verified
Biomarkers for early diagnosis of pancreatic cancer
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, W., Neoptolemos, J., & Costello, E. (2015) · Expert Review of Gastroenterology & Hepatology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 42
- Verified
Identification of cystic lesions by secondary screening of familial pancreatic cancer (FPC) kindreds is not associated with the stratified risk of cancer
Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., Raraty, M., Ramesh, J., Farooq, A., Costello, E., et al. (2019) · American Journal of Gastroenterology
Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancer
Cited by 36
- Verified
No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma
Grützmann, R., McFaul, C., Bartsch, D. K., Sina-Frey, M., Rieder, H., Koch, R., McCarthy, E., Greenhalf, W., Neoptolemos, J. P., Saeger, H. D., et al. (2004) · Cancer Letters
Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancer
Cited by 23
- Verified
A multistate modelling approach for pancreatic cancer development in genetically high-risk families
Kolamunnage-Dona, R., Vitone, L., Greenhalf, W., Henderson, R., & Williamson, P. R. (2013) · Journal of the Royal Statistical Society Series C: Applied Statistics
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free